Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Osteosarcoma
Related studies linked through entity extraction aliases.
A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
- Status
- RECRUITING
- Phase
- N/A
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
- Status
- AVAILABLE
- Phase
- N/A
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
- Status
- RECRUITING
- Phase
- NA
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- Status
- RECRUITING
- Phase
- PHASE2
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS
- Status
- COMPLETED
- Phase
- N/A
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Proteomics Research of Osteosarcoma
- Status
- UNKNOWN
- Phase
- N/A
Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival
- Status
- COMPLETED
- Phase
- N/A
Losartan + Sunitinib in Treatment of Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
M6620 (VX-970) in Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1